Tag Archives: Teva

On Tuesday, the U.S. Supreme Court issued its decision in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. partially modifying the standard of review to be applied by the Federal Circuit when reviewing a district court’s construction of a claim term. Prior … Continue reading

Posted in Patent Litigation | Tagged , , , , , , , , , , | Comments Off on Supreme Court Modifies Claim Construction Review Standard